Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1
- PMID: 1302044
- DOI: 10.1097/00008571-199204000-00004
Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1
Abstract
Six human cytochrome P450s expressed in HepG2 cells using vaccinia virus cDNA-directed expression, were used to study the biotransformation of caffeine and its metabolites. CYP1A2 alone was responsible for caffeine 3-demethylation and paraxanthine 7-demethylation; in addition, 1A2 catalysed virtually all reactions related to caffeine and its metabolites. The metabolic profile of caffeine biotransformation by CYP1A2 averaged 81.5% for paraxanthine, 10.8% for theobromine and 5.4% for theophylline formation. It remained quite uniform when caffeine concentrations were varied. The most striking finding was that CYP2E1 (the ethanol-inducible form) had major influences upon caffeine metabolism: in particular, it catalysed the formation of theophylline and theobromine from caffeine. Thus, the in vivo metabolite profiling of caffeine may reveal CYP2E1 activities in addition to the previously documented activities of CYP1A2, polymorphic N-acetyltransferase and xanthine oxidase.
Similar articles
-
Caffeine as a probe for human cytochromes P450: validation using cDNA-expression, immunoinhibition and microsomal kinetic and inhibitor techniques.Pharmacogenetics. 1992 Aug;2(4):173-83. doi: 10.1097/00008571-199208000-00004. Pharmacogenetics. 1992. PMID: 1306118
-
Biotransformation of caffeine, paraxanthine, theophylline, and theobromine by polycyclic aromatic hydrocarbon-inducible cytochrome(s) P-450 in human liver microsomes.Drug Metab Dispos. 1987 Mar-Apr;15(2):237-49. Drug Metab Dispos. 1987. PMID: 2882985
-
Interaction between two probes used for phenotyping cytochromes P4501A2 (caffeine) and P4502E1 (chlorzoxazone) in humans.Pharmacogenetics. 1995 Apr;5(2):72-9. doi: 10.1097/00008571-199504000-00003. Pharmacogenetics. 1995. PMID: 7663531
-
Measurement of CYP1A2 activity: a focus on caffeine as a probe.Curr Drug Metab. 2012 Jun 1;13(5):667-78. doi: 10.2174/1389200211209050667. Curr Drug Metab. 2012. PMID: 22554278 Review.
-
Catabolic pathways and biotechnological applications of microbial caffeine degradation.Biotechnol Lett. 2006 Dec;28(24):1993-2002. doi: 10.1007/s10529-006-9196-2. Epub 2006 Sep 29. Biotechnol Lett. 2006. PMID: 17009088 Review.
Cited by
-
CYP1A2 genotype and rheumatoid arthritis in Koreans.Rheumatol Int. 2010 Aug;30(10):1349-54. doi: 10.1007/s00296-009-1050-0. Epub 2009 Jul 5. Rheumatol Int. 2010. PMID: 19579025
-
Induction of P-450 in workers exposed to dioxin.Occup Environ Med. 1995 Feb;52(2):86-91. doi: 10.1136/oem.52.2.86. Occup Environ Med. 1995. PMID: 7757172 Free PMC article.
-
Hypoxia, arterial pH and theophylline disposition.Clin Pharmacokinet. 1993 Oct;25(4):283-99. doi: 10.2165/00003088-199325040-00004. Clin Pharmacokinet. 1993. PMID: 8261713 Review.
-
Multiscale modeling reveals inhibitory and stimulatory effects of caffeine on acetaminophen-induced toxicity in humans.CPT Pharmacometrics Syst Pharmacol. 2017 Feb;6(2):136-146. doi: 10.1002/psp4.12153. Epub 2017 Jan 28. CPT Pharmacometrics Syst Pharmacol. 2017. PMID: 28130915 Free PMC article.
-
Caffeine-Containing Energy Shots Cause Acute Impaired Glucoregulation in Adolescents.Nutrients. 2020 Dec 16;12(12):3850. doi: 10.3390/nu12123850. Nutrients. 2020. PMID: 33339359 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases